Share Wealth

Market
  • Markets Navigation
    Company Info.

    Novelix Pharmaceuticals Ltd.

    Shareholding Pattern


    Market Cap.(`) 24.03 Cr. P/BV 2.61 Book Value (`) 9.25
    52 Week High/Low ( ` ) 24/8 FV/ML 10/1 P/E(X) 2,415.00
    Book Closure 27/09/2024 EPS (`) 0.01 Div Yield (%) 0.00
    You can view the shareholding pattern for the latest two quarters for the company under two broad categories (Promoter & Non Promters).

    •  

    Shareholding Pattern as on 30/09/2024
    Summary statement holding of specified securities
    Category of shareholder Nos. of shareholders No. of fully paid up equity shares held Total nos. shares held Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2) Shareholding as a % assuming full conversion of convertible securities (as a percentage of diluted share capital) As a % of (A+B+C2) No. of Locked in shares - No.(a) No. of Locked in shares - As a % of total shares held(b) Number of equity shares held in dematerialized form
    (A) Promoter & Promoter Group 4 6622733 6622733 66.56 66.56 1550000 23.40 6622733
    (B) Public 2529 3327267 3327267 33.44 33.44 300000 9.02 2999057
    (C1) Shares underlying DRs 0 0 0 0.00 0.00 0 0.00 0
    (C2) Shares held by Employee Trust 0 0 0 0.00 0.00 0 0.00 0
    (C) Non Promoter-Non Public 0 0 0 0.00 0.00 0 0.00 0
    Grand Total 2533 9950000 9950000 100.00 100.00 1850000 18.59 9621790

    Category of shareholder Nos. of shareholders No. of fully paid up equity shares held No. of shares underlying Depository Receipts Total nos. shares held Shareholding as a % of total no. of shares (calculated as per SCRR, 1957)As a % of (A+B+C2) Number of equity shares held in dematerialized form
    Shareholding of Promoter and Promoter Group
    Indian
    Individuals / Hindu Undivided Family 3 1620733 0 1620733 16.29 1620733
    Vupparapalli Chandrasekhar Reddy 1 870733 0 870733 8.75 870733
    Vupparapalli Pavani 1 400000 0 400000 4.02 400000
    Gattu Gnana Prakash 1 350000 0 350000 3.52 350000
    Any Other (specify) 1 5002000 0 5002000 50.27 5002000
    Srinidhi Fine-Chemicals LLP 1 5002000 0 5002000 50.27 5002000
    Grand Total466227330662273366.566622733
    Public Shareholding
    Non-Institutions
    Any Others (Specify) 1 1 0 1 0.00 1
    Bodies Corporate 24 1158487 0 1158487 11.64 1150387
    TDPL HEALTH CARE (INDIA) LLP 1 350000 0 350000 3.52 350000
    SOURA INVESTMENTS HOLDINGS PRIVATE LIMITED 1 270000 0 270000 2.71 270000
    DM FINCON SERVICES LLP 1 250000 0 250000 2.51 250000
    MEDO CAPITAL SERVICES PRIVATE LIMITED 1 125000 0 125000 1.26 125000
    Resident Individuals holding nominal share capital up to Rs. 2 lakhs 2480 927052 0 927052 9.32 641642
    Resident Individuals holding nominal share capital in excess of Rs. 2 lakhs 19 1074898 0 1074898 10.80 1040198
    PANCHAGNULA VENKATA LAKSHMI NARAYANA SANKARA VARA PRASAD 1 225000 0 225000 2.26 225000
    SESHA SAI NIKHIL CHINTALAPATI 1 100000 0 100000 1.01 100000
    SRINIVASRAO SWETHA KANAKAPUR 1 100000 0 100000 1.01 100000
    Non Resident Indians (NRIs) 4 31829 0 31829 0.32 31829
    Investor Education and Protection Fund (IEPF) 1 135000 0 135000 1.36 135000
    Sub Total252933272670332726733.442999057
    Grand Total252933272670332726733.442999057

  • Novelix Pharmaceuticals Ltd.

    Products & Raw Material


    Market Cap.(`) 24.03 Cr. P/BV 2.61 Book Value (`) 9.25
    52 Week High/Low ( ` ) 24/8 FV/ML 10/1 P/E(X) 2,415.00
    Book Closure 27/09/2024 EPS (`) 0.01 Div Yield (%) 0.00

    You can view the entire product & raw materials mix with Product names, Sales quantity & Value along with percentage contribution from each individual product.

    Product Report
    Product NameYearMonthSales QuantityUOMSales Value (` Crs.)Product Mix (%)
    Income From Sale Of Share & Securities2024120.00-4.1297.42
    Pharmaceuticals2024120.00-0.112.57
    Raw Material Report
    Product NameYear/MonthSales QuantityUOMSales Value (` Crs)Product Mix (%)
    Not Applicable24/030.00Not Applicable0.000.00
Attention Investors : “Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |     |  ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.   |  "Revised guidelines on margin collection ==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors"   |  ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600   |  For any Grievance mail to : grievance@sharewealthindia.com   |  For any DP Grievance mail to : dpgrievance@sharewealthindia.com.   |  Grievance with SEBI : https://scores.gov.in/scores/Welcome.html